Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A unified model of ketamine’s dissociative and psychedelic properties
M. Marguilho, I. Figueiredo, Pedro Castro-Rodrigues
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 14-32
Open Access | Times Cited: 20

Showing 20 citing articles:

Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
Nature heals: an informational entropy account of self-organization and change in field psychotherapy
Pietro Sarasso, Wolfgang Tschacher, Félix Schoeller, et al.
Physics of Life Reviews (2024) Vol. 51, pp. 64-84
Closed Access | Times Cited: 6
Ketamine in insulin resistance: Pharmacokinetics, cardiovascular implications and cellular effects on cardiomyocytes
Ariana Ramirez, Stephanie Howes, Robert Ćhilton
Diabetes Obesity and Metabolism (2025)
Closed Access
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8
Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report
Anya Ragnhildstveit, Miriam Kaiyo, Matthew Brian Snyder, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 7
Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
Magdalena Więdłocha, Piotr Marcinowicz, Jan Komarnicki, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Disembodiment and Affective Resonances in Esketamine Treatment of Depersonalized Depression Subtype: Two Case Studies
Pietro Sarasso, Martina Billeci, Irene Ronga, et al.
Psychopathology (2024), pp. 1-12
Closed Access | Times Cited: 2
Learning how to make use of dissociative therapies
David S. Mathai
International Review of Psychiatry (2024), pp. 1-13
Closed Access | Times Cited: 2
The cognitive neuroscience of self‐awareness: Current framework, clinical implications, and future research directions
Daniel C. Mograbi, Simon J. Hall, Beatriz Arantes, et al.
Wiley Interdisciplinary Reviews Cognitive Science (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 6
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 270-270
Open Access | Times Cited: 1
Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms
Piotr Kawczak, Igor Feszak, Tomasz Bączek
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2283-2283
Open Access | Times Cited: 1
Suicide prevention and ketamine: insights from computational modeling
Colleen E. Charlton, Povilas Karvelis, Roger S. McIntyre, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers
David S. Mathai, Samantha Hilbert, Nathan D. Sepeda, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 4, pp. 241-252
Closed Access | Times Cited: 4
Long-Term Effects of Single and Repeated Ketamine Infusions on Treatment-Resistant Depression: A Retrospective Chart Review Study
Sofia Sakopoulos, Lisa D. Hinz
Psychoactives (2024) Vol. 3, Iss. 4, pp. 501-512
Open Access | Times Cited: 1
Ketamine: A new chapter for clinical psychopharmacology?
Allan H. Young
Journal of Psychopharmacology (2023) Vol. 37, Iss. 8, pp. 755-756
Open Access | Times Cited: 3
Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm
Henry A. MacConnel, Mitch Earleywine, Steven Radowitz
(2024)
Open Access
Ketamin und Esketamin
Cornelius Schüle, Gabi Koller, Uwe Herwig
Nervenheilkunde (2024) Vol. 43, Iss. 06, pp. 366-373
Closed Access
“Angry at the Wrong Thing:” Queering Ketamine Assisted Psychotherapy for Clients Experiencing Body Image and Eating Distress
Jessalyn Maguire
Deleted Journal (2024) Vol. 94, Iss. 4, pp. 340-361
Closed Access
Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm
Henry A. MacConnel, Mitch Earleywine, Steven Radowitz
Journal of Psychopharmacology (2024)
Open Access
Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches
Daniella Batievsky, Michelle D. Weiner, S. Kaplan, et al.
Frontiers in Pain Research (2023) Vol. 4
Open Access
Page 1

Scroll to top